Valuation: PROCEPT BioRobotics Corporation

Market Cap 1.14B 989M 926M 847M 1.6B 109B 1.62B 10.84B 4.25B 54.26B 4.28B 4.19B 181B P/E 2026 *
-12x
P/E 2027 * -18.7x
Enterprise Value 1.03B 894M 837M 765M 1.45B 98.1B 1.46B 9.79B 3.84B 49.01B 3.87B 3.78B 163B EV / Sales 2026 *
2.6x
EV / Sales 2027 * 2.15x
Free-Float
96.83%
Yield 2026 *
-
Yield 2027 * -
1 day+3.57%
1 week+11.28%
Current month+7.57%
1 month-5.56%
3 months-19.23%
6 months-30.31%
Current year-36.33%
1 week 17.12
Extreme 17.12
20.06
1 month 16.66
Extreme 16.665
21.56
Current year 16.66
Extreme 16.665
35.4
1 year 16.66
Extreme 16.665
42.7
3 years 16.66
Extreme 16.665
103.81
5 years 15.38
Extreme 15.38
103.81
10 years 15.38
Extreme 15.38
103.81
Manager TitleAgeSince
Chief Executive Officer 60 2025-09-01
Director of Finance/CFO 48 2018-09-30
Chief Operating Officer 56 2026-02-28
Director TitleAgeSince
Chairman 74 2021-02-28
Director/Board Member 48 2015-05-31
Director/Board Member 50 2020-11-30
Date Insider Type Main position Quantity % Market Cap.
6/8/26 Sell

Chief Financial Officer

-357 0.0006%
6/8/26 Sell

General Counsel

-285 0.0005%
3/5/26 Free

Chief Executive Officer

231,436 0.4142%
Change 5-day change 1-year change 3-year change Capi.($)
+3.57%+11.28%-56.16%-42.31% 1.1B
+2.13%+2.23%-17.54%+0.29% 183B
-0.08%+0.25%-3.85%+2.24% 110B
+2.46%+4.09%+14.53%+75.37% 61.72B
+0.57%+7.59%+37.31%+53.50% 54.98B
+3.76%+7.02%+2.70%-34.61% 47.02B
-5.88%-11.78% - - 32.16B
+0.44%+11.38%+8.66%-31.01% 31.19B
-0.69%+2.65%+46.92%-7.06% 24.7B
-0.40%+0.25%+4.78%+2.55% 22.68B
Average +0.60%+3.52%+4.15%+2.11% 56.85B
Weighted average by Cap. +0.97%+2.72%+1.71%+9.57%

Financials

2026 *2027 *
Net sales 395M 343M 321M 294M 555M 37.67B 562M 3.76B 1.48B 18.82B 1.48B 1.45B 62.64B 477M 414M 387M 354M 669M 45.42B 678M 4.53B 1.78B 22.69B 1.79B 1.75B 75.54B
Net income -94.81M -82.28M -77.05M -70.48M -133M -9.03B -135M -901M -354M -4.51B -356M -348M -15.02B -63.08M -54.74M -51.26M -46.89M -88.51M -6.01B -89.67M -600M -235M -3B -237M -232M -9.99B
Net Debt -110M -95.72M -89.63M -81.99M -155M -10.51B -157M -1.05B -412M -5.25B -414M -405M -17.47B -115M -100M -93.67M -85.68M -162M -10.98B -164M -1.1B -430M -5.49B -433M -423M -18.26B
Logo PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are advanced, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia (BPH). It designed Aquablation therapy to deliver outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH that is independent of prostate size and shape and delivers resection independent of surgeon experience. It manufactures the robotic systems, the single-use disposable handpiece, integrated scope and other accessories at its facility in San Jose, California. Each robotic system is shipped to its customers with a third-party manufactured ultrasound system and probe.
Employees
888
Date Price Change Volume
26-08-06 US$20.03 +3.57% 2,301,864
26-08-05 US$19.34 +5.80% 5,458,860
26-08-04 US$18.28 -0.54% 3,732,992
26-08-03 US$18.38 -1.29% 2,900,588
26-07-31 US$18.62 +3.44% 1,179,280
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
20.03USD
Average target price
21.30USD
Spread / Average Target
+6.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PRCT Stock